New injection could shrink livers and ease pain in rare disease
NCT ID NCT05281328
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 16 times
Summary
This study tests a new long-acting octreotide injection (CAM2029) in 71 adults with symptomatic polycystic liver disease. Participants receive weekly or biweekly injections or a placebo for 53 weeks to see if the drug reduces liver size and improves symptoms like bloating, pain, and fullness. The trial is active but no longer recruiting, and an open-label extension allows continued treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bon Secours Richmond Community Hospital
Richmond, Virginia, 23602, United States
-
Hannover Medical School
Hanover, 30625, Germany
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mount Sinai Hospital
New York, New York, 10029, United States
-
Radboud UMC, Department of Gastroenterology and Hepatology
Nijmegen, 6525 GA, Netherlands
-
The New York Presbyterian Hospital
New York, New York, 10065, United States
-
Universitaetsklinikum Müenster
Münster, 48149, Germany
-
University Hospitals KU Leuven
Leuven, B-3000, Belgium
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75380, United States
-
Universitätsklinikum Leipzig
Leipzig, 04103, Germany
Conditions
Explore the condition pages connected to this study.